The FDA Refuses To Review Moderna’s Flu Vaccine
- Posted on February 11, 2026
- By Forbes
- 2 Views
The FDA Refuses To Review Moderna’s Flu Vaccine
In this week’s edition of InnovationRx, we look at the healthcare giants on Forbes new Greatest Innovators list, why Garner Health is worth $1.35 billion, and more.
